Study: Diabetes patients may do better with everolimus stents

04/7/2013 | Healio

Data on 968 diabetes patients who had percutaneous coronary intervention revealed those who used paclitaxel-eluting stents had higher thrombosis rates at six and 12 months and higher mortality at one year compared with those who were treated with everolimus-eluting stents. The findings appear in Catheterization and Cardiovascular Interventions.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX